Literature DB >> 2041956

Four decades of shigellosis in Israel: epidemiology of a growing public health problem.

M S Green1, C Block, D Cohen, P E Slater.   

Abstract

Despite the improved standard of living in Israel, shigellosis remains a common disease. Examination of trends in the incidence of shigellosis in Israel between 1951 and 1987 showed a period of declining rates followed by an increase in the reported incidence beginning around 1969. This increase was mainly due to Shigella sonnei; rates of infection with Shigella flexneri remained relatively constant. Trends showed marked differences between age groups and between ethnic groups. In comparison, the rates in the United States--much lower than those in Israel--began to decline in the early 1950s and have remained low. The incidence in Israel is now about 20 times higher than that in the United States. Thus shigellosis remains a major and growing public health problem in Israel, a country that has enjoyed a dramatic improvement in basic sanitary services and infrastructure over the past few decades. This disturbing finding lends urgency to efforts to control the disease.

Entities:  

Mesh:

Year:  1991        PMID: 2041956     DOI: 10.1093/clinids/13.2.248

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  16 in total

1.  Retrospective analysis of the first clonal outbreak of nalidixic acid-resistant Shigella sonnei shigellosis in Israel.

Authors:  D Dagan; N Orr; M Yavzori; Y Yuhas; D Meron; S Ashkenazi; D Cohen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-10       Impact factor: 3.267

2.  Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers.

Authors:  D Cohen; S Ashkenazi; M Green; Y Lerman; R Slepon; G Robin; N Orr; D N Taylor; J C Sadoff; C Chu; J Shiloach; R Schneerson; J B Robbins
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

3.  Evaluation of commercial antisera for Shigella serogrouping.

Authors:  J Lefebvre; F Gosselin; J Ismaïl; M Lorange; H Lior; D Woodward
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

4.  Recovery and characterization of environmental variants of Shigella flexneri from surface water in Bangladesh.

Authors:  Mohammed Ziaur Rahman; Nafisa Azmuda; Mohammad Jahangir Hossain; Munawar Sultana; Sirajul Islam Khan; Nils-Kåre Birkeland
Journal:  Curr Microbiol       Date:  2011-08-09       Impact factor: 2.188

5.  Serological cross-reaction between O-antigens of Shigella dysenteriae type 4 and an environmental Escherichia albertii isolate.

Authors:  Mohammed Ziaur Rahman; Selina Akter; Nafisa Azmuda; Munawar Sultana; François-Xavier Weill; Sirajul Islam Khan; Patrick A D Grimont; Nils-Kåre Birkeland
Journal:  Curr Microbiol       Date:  2013-06-09       Impact factor: 2.188

6.  Socioeconomic correlates of antibody levels to enteric pathogens among Israeli adolescents.

Authors:  T Hasin; R Dagan; G Boutboul; E Derazne; O Atias; D Cohen
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

7.  Molecular epidemiology of Shigella infections in Israel.

Authors:  M Yavzori; D Cohen; H Bercovier
Journal:  Epidemiol Infect       Date:  1992-10       Impact factor: 2.451

8.  Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.

Authors:  D N Taylor; A C Trofa; J Sadoff; C Chu; D Bryla; J Shiloach; D Cohen; S Ashkenazi; Y Lerman; W Egan
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  Identification of Shigella species in stool specimens by DNA amplification of different loci of the Shigella virulence plasmid.

Authors:  M Yavzori; D Cohen; R Wasserlauf; R Ambar; G Rechavi; S Ashkenazi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

10.  Activities of newer fluoroquinolones against Shigella sonnei.

Authors:  J F John; L T Atkins; P A Maple; M Bratoeva
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.